
Guillaume BlivetREGEnLIFE · Board of Directors
Guillaume Blivet
Master of Public Health
About
8
Publications
564
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
29
Citations
Citations since 2017
Publications
Publications (8)
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer's Disease? Design of a pivotal sham-controlled randomized, double blind, multicentric clinical investigation.
Quantitative phase microscopies (QPMs) enable label-free, non-invasive observation of living cells in culture, for arbitrarily long periods of time. One of the main benefits of QPMs compared with fluorescence microscopy is the possibility to measure the dry mass of individual cells or organelles. While QPM dry mass measurements on neural cells have...
Background:
Recent innovative non-pharmacological interventions and neurostimulation devices have shown potential for application in the treatment of Alzheimer's disease (AD). These include photobiomodulation (PBM) therapy.
Objective:
This pilot study assesses the safety, compliance with, and efficacy of a brain-gut PBM therapy for mild-to-moder...
Introduction
Photobiomodulation was assessed as a novel treatment of Alzheimer’s disease (AD) by the use of a new device RGn500 combining photonic and magnetic emissions in a mouse model of AD.
Methods
Following the injection of amyloid β 25-35 peptide in male Swiss mice, RGn500 was applied once a day for 7 days either on the top of the head or th...
Projects
Project (1)